Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2005;96:110-118
Published online before print December 2, 2004, doi: 10.1161/01.RES.0000152326.91223.4F
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
96/1/110    most recent
01.RES.0000152326.91223.4Fv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pasumarthi, K. B.S.
Right arrow Articles by Field, L. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pasumarthi, K. B.S.
Right arrow Articles by Field, L. J.
Related Collections
Right arrow Other myocardial biology
Right arrow Cell biology/structural biology
Right arrow Genetically altered mice
(Circulation Research. 2005;96:110.)
© 2005 American Heart Association, Inc.


Integrative Physiology

Targeted Expression of Cyclin D2 Results in Cardiomyocyte DNA Synthesis and Infarct Regression in Transgenic Mice

Kishore B.S. Pasumarthi, Hidehiro Nakajima, Hisako O. Nakajima, Mark H. Soonpaa, Loren J. Field

From the Wells Center for Pediatric Research and Krannert Institute of Cardiology, Indiana University School of Medicine, Indianapolis, Ind. Present address of K.B.S. Pasumarthi is Dalhousie University, Halifax, Canada.

Correspondence to Loren J. Field, Herman B Wells Center for Pediatric Research, James Whitcomb Riley Hospital for Children, 1044 West Walnut St, R4-W376, Indianapolis, IN 46202-5225. E-mail ljfield{at}iupui.edu

Restriction point transit and commitment to a new round of cell division is regulated by the activity of cyclin-dependent kinase 4 and its obligate activating partners, the D-type cyclins. In this study, we examined the ability of D-type cyclins to promote cardiomyocyte cell cycle activity. Adult transgenic mice expressing cyclin D1, D2, or D3 under the regulation of the {alpha} cardiac myosin heavy chain promoter exhibited high rates of cardiomyocyte DNA synthesis under baseline conditions. Cardiac injury in mice expressing cyclin D1 or D3 resulted in cytoplasmic cyclin D accumulation, with a concomitant reduction in the level of cardiomyocyte DNA synthesis. In contrast, cardiac injury in mice expressing cyclin D2 did not alter subcellular cyclin localization. Consequently, cardiomyocyte cell cycle activity persisted in injured hearts expressing cyclin D2, ultimately resulting in infarct regression. These data suggested that modulation of D-type cyclins could be exploited to promote regenerative growth in injured hearts.


Key Words: cardiomyocyte proliferation • DNA synthesis • heart regeneration




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
Z. Qiu, Y. Cang, and S. P. Goff
c-Abl tyrosine kinase regulates cardiac growth and development
PNAS, January 19, 2010; 107(3): 1136 - 1141.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. J. van Amerongen, F. Diehl, T. Novoyatleva, C. Patra, and F. B. Engel
E2F4 is required for cardiomyocyte proliferation
Cardiovasc Res, December 30, 2009; (2009) cvp383v2.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
L. Ding, L. Dong, X. Chen, L. Zhang, X. Xu, A. Ferro, and B. Xu
Increased Expression of Integrin-Linked Kinase Attenuates Left Ventricular Remodeling and Improves Cardiac Function After Myocardial Infarction
Circulation, September 1, 2009; 120(9): 764 - 773.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
R J Hassink, H Nakajima, H O Nakajima, P A Doevendans, and L J Field
Expression of a transgene encoding mutant p193/CUL7 preserves cardiac function and limits infarct expansion after myocardial infarction
Heart, July 15, 2009; 95(14): 1159 - 1164.
[Abstract] [Full Text] [PDF]


Home page
Ther Adv Cardiovasc DisHome page
C. Stamm, Y.-H. Choi, B. Nasseri, and R. Hetzer
A heart full of stem cells: the spectrum of myocardial progenitor cells in the postnatal heart
Therapeutic Advances in Cardiovascular Disease, June 1, 2009; 3(3): 215 - 229.
[Abstract] [PDF]


Home page
J. Cell Sci.Home page
Q. Sun, F. Zhang, K. Wafa, T. Baptist, and K. B. S. Pasumarthi
A splice variant of cyclin D2 regulates cardiomyocyte cell cycle through a novel protein aggregation pathway
J. Cell Sci., May 15, 2009; 122(10): 1563 - 1573.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
S. Ausoni and S. Sartore
From fish to amphibians to mammals: in search of novel strategies to optimize cardiac regeneration
J. Cell Biol., February 9, 2009; 184(3): 357 - 364.
[Abstract] [Full Text] [PDF]


Home page
Asian Cardiovasc. Thorac. Ann.Home page
R. L Kao, W. Browder, and C. Li
Cellular Cardiomyoplasty: What Have We Learned?
Asian Cardiovasc Thorac Ann, January 1, 2009; 17(1): 89 - 101.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
N. Liu, S. Bezprozvannaya, A. H. Williams, X. Qi, J. A. Richardson, R. Bassel-Duby, and E. N. Olson
microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart
Genes & Dev., December 1, 2008; 22(23): 3242 - 3254.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. Tamamori-Adachi, H. Takagi, K. Hashimoto, K. Goto, T. Hidaka, U. Koshimizu, K. Yamada, I. Goto, Y. Maejima, M. Isobe, et al.
Cardiomyocyte proliferation and protection against post-myocardial infarction heart failure by cyclin D1 and Skp2 ubiquitin ligase
Cardiovasc Res, November 1, 2008; 80(2): 181 - 190.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
T. A. Gorr and A. Deten
Manipulating myocyte cell cycle control for cardiac repair
Cardiovasc Res, November 1, 2008; 80(2): 161 - 162.
[Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
A. Rojas, S. W. Kong, P. Agarwal, B. Gilliss, W. T. Pu, and B. L. Black
GATA4 Is a Direct Transcriptional Activator of Cyclin D2 and Cdk4 and Is Required for Cardiomyocyte Proliferation in Anterior Heart Field-Derived Myocardium
Mol. Cell. Biol., September 1, 2008; 28(17): 5420 - 5431.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Qiu, H. Dai, K. Jain, R. Shah, C. Hong, J. Pain, B. Tian, D. E. Vatner, S. F. Vatner, and C. Depre
Characterization of a Novel Cardiac Isoform of the Cell Cycle-related Kinase That Is Regulated during Heart Failure
J. Biol. Chem., August 8, 2008; 283(32): 22157 - 22165.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
E. Angelis, A. Garcia, S. S. Chan, K. Schenke-Layland, S. Ren, S. J. Goodfellow, M. C. Jordan, K. P. Roos, R. J. White, and W. R. MacLellan
A Cyclin D2-Rb Pathway Regulates Cardiac Myocyte Size and RNA Polymerase III After Biomechanical Stress in Adult Myocardium
Circ. Res., May 23, 2008; 102(10): 1222 - 1229.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. D.T. Costa
Divide to survive: myocardial regeneration and functional recovery after cell cycle activation in injured hearts
Cardiovasc Res, April 1, 2008; 78(1): 1 - 2.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. J. Hassink, K. B. Pasumarthi, H. Nakajima, M. Rubart, M. H. Soonpaa, A. B. de la Riviere, P. A. Doevendans, and L. J. Field
Cardiomyocyte cell cycle activation improves cardiac function after myocardial infarction
Cardiovasc Res, April 1, 2008; 78(1): 18 - 25.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. L. Hall
Discovery of an Intricate Balance: Gene Transcription, Cell Cycle, and Apoptosis
Circ. Res., February 29, 2008; 102(4): 395 - 397.
[Full Text] [PDF]


Home page
Circ. Res.Home page
R. K. Cheng, T. Asai, H. Tang, N. H. Dashoush, R. J. Kara, K. D. Costa, Y. Naka, E. X. Wu, D. J. Wolgemuth, and H. W. Chaudhry
Cyclin A2 Induces Cardiac Regeneration After Myocardial Infarction and Prevents Heart Failure
Circ. Res., June 22, 2007; 100(12): 1741 - 1748.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
W. A. LaFramboise, D. Scalise, P. Stoodley, S. R. Graner, R. D. Guthrie, J. A. Magovern, and M. J. Becich
Cardiac fibroblasts influence cardiomyocyte phenotype in vitro
Am J Physiol Cell Physiol, May 1, 2007; 292(5): C1799 - C1808.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
Y. J. Woo, C. M. Panlilio, R. K. Cheng, G. P. Liao, E. E. Suarez, P. Atluri, and H. W. Chaudhry
Myocardial regeneration therapy for ischemic cardiomyopathy with cyclin A2
J. Thorac. Cardiovasc. Surg., April 1, 2007; 133(4): 927 - 933.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
P. Ahuja, P. Sdek, and W. R. MacLellan
Cardiac Myocyte Cell Cycle Control in Development, Disease, and Regeneration
Physiol Rev, April 1, 2007; 87(2): 521 - 544.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
F. B. Engel, P. C. H. Hsieh, R. T. Lee, and M. T. Keating
FGF1/p38 MAP kinase inhibitor therapy induces cardiomyocyte mitosis, reduces scarring, and rescues function after myocardial infarction
PNAS, October 17, 2006; 103(42): 15546 - 15551.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
W.-H. Zimmermann, M. Didie, S. Doker, I. Melnychenko, H. Naito, C. Rogge, M. Tiburcy, and T. Eschenhagen
Heart muscle engineering: An update on cardiac muscle replacement therapy
Cardiovasc Res, August 1, 2006; 71(3): 419 - 429.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Y. J. Woo, C. M. Panlilio, R. K. Cheng, G. P. Liao, P. Atluri, V. M. Hsu, J. E. Cohen, and H. W. Chaudhry
Therapeutic Delivery of Cyclin A2 Induces Myocardial Regeneration and Enhances Cardiac Function in Ischemic Heart Failure
Circulation, July 4, 2006; 114(1_suppl): I-206 - I-213.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
X. Chen, S. P. Shevtsov, E. Hsich, L. Cui, S. Haq, M. Aronovitz, R. Kerkela, J. D. Molkentin, R. Liao, R. N. Salomon, et al.
The {beta}-Catenin/T-Cell Factor/Lymphocyte Enhancer Factor Signaling Pathway Is Required for Normal and Stress-Induced Cardiac Hypertrophy
Mol. Cell. Biol., June 15, 2006; 26(12): 4462 - 4473.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. Anversa, A. Leri, and J. Kajstura
Cardiac Regeneration
J. Am. Coll. Cardiol., May 2, 2006; 47(9): 1769 - 1776.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. Anversa, J. Kajstura, A. Leri, and R. Bolli
Life and Death of Cardiac Stem Cells: A Paradigm Shift in Cardiac Biology
Circulation, March 21, 2006; 113(11): 1451 - 1463.
[Full Text] [PDF]


Home page
Circ. Res.Home page
H. Nakajima, H. O. Nakajima, K. Dembowsky, K. B.S. Pasumarthi, and L. J. Field
Cardiomyocyte Cell Cycle Activation Ameliorates Fibrosis in the Atrium
Circ. Res., January 6, 2006; 98(1): 141 - 148.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
G. M. Ledda-Columbano, F. Molotzu, M. Pibiri, C. Cossu, A. Perra, and A. Columbano
Thyroid hormone induces cyclin D1 nuclear translocation and DNA synthesis in adult rat cardiomyocytes
FASEB J, January 1, 2006; 20(1): 87 - 94.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
F. B. Engel, M. Schebesta, M. T. Duong, G. Lu, S. Ren, J. B. Madwed, H. Jiang, Y. Wang, and M. T. Keating
p38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes
Genes & Dev., May 15, 2005; 19(10): 1175 - 1187.
[Abstract] [Full Text] [PDF]